143 related articles for article (PubMed ID: 31001910)
1. Primary neuroendocrine carcinoma of the breast.
Bergstrom C; Porembka J; Fang Y; Sarode V; Syed S
Breast J; 2019 May; 25(3):519-520. PubMed ID: 31001910
[No Abstract] [Full Text] [Related]
2. Solid neuroendocrine breast carcinoma: mammographic and sonographic features in thirteen cases.
Wu J; Yang QX; Wu YP; Wang DL; Liu XW; Cui CY; Wang L; Chen Y; Xie CM; Zhang R
Chin J Cancer; 2012 Nov; 31(11):549-56. PubMed ID: 22640624
[TBL] [Abstract][Full Text] [Related]
3. Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy.
Lee MC; Gonzalez SJ; Lin H; Zhao X; Kiluk JV; Laronga C; Mooney B
Ann Surg Oncol; 2015 Sep; 22(9):2888-94. PubMed ID: 25589151
[TBL] [Abstract][Full Text] [Related]
4. Effective role of hormonal therapy in metastatic primary neuroendocrine breast carcinoma.
Buttar A; Mittal K; Khan A; Bathini V
Clin Breast Cancer; 2011 Oct; 11(5):342-5. PubMed ID: 21729664
[TBL] [Abstract][Full Text] [Related]
5. Primary neuroendocrine carcinoma of the breast, which chemotherapy?
El Hassani LK; Bensouda Y; M'Rabti H; Boutayeb S; Kamouni M; Gamra L; Errihani H
Indian J Cancer; 2009; 46(4):352-4. PubMed ID: 19749475
[No Abstract] [Full Text] [Related]
6. A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206).
Eba J; Kenmotsu H; Tsuboi M; Niho S; Katayama H; Shibata T; Watanabe S; Yamamoto N; Tamura T; Asamura H; ;
Jpn J Clin Oncol; 2014 Apr; 44(4):379-82. PubMed ID: 24474818
[TBL] [Abstract][Full Text] [Related]
7. Problems with the progesterone receptor in practice?
Jordan VC; Gelber RD
J Clin Oncol; 2007 May; 25(15):1957-9. PubMed ID: 17452674
[No Abstract] [Full Text] [Related]
8. Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma.
Sørbye H; Westre B; Horn A
Eur J Surg Oncol; 2007 Dec; 33(10):1209-10. PubMed ID: 17350785
[No Abstract] [Full Text] [Related]
9. Solitary esophageal metastasis of breast cancer after 11 years: a case report.
Erman M; Karaoğlu A; Oksüzoğlu B; Aydingöz U; Ayhan A; Güler N
Med Oncol; 2002; 19(3):171-5. PubMed ID: 12482128
[TBL] [Abstract][Full Text] [Related]
10. [Case of primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy].
Hasegawa H; Kuzushita N; Nakazuru S; Itoh M; Araki M; Yoshioka C; Suemura S; Ohta M; Yoshio T; Toyama T; Ikura Y; Mita E
Nihon Shokakibyo Gakkai Zasshi; 2010 Dec; 107(12):1956-62. PubMed ID: 21139365
[TBL] [Abstract][Full Text] [Related]
11. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
De Maeyer L; Van Limbergen E; De Nys K; Moerman P; Pochet N; Hendrickx W; Wildiers H; Paridaens R; Smeets A; Christiaens MR; Vergote I; Leunen K; Amant F; Neven P
J Clin Oncol; 2008 Jan; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
[No Abstract] [Full Text] [Related]
12. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
Iwasa S; Morizane C; Okusaka T; Ueno H; Ikeda M; Kondo S; Tanaka T; Nakachi K; Mitsunaga S; Kojima Y; Hagihara A; Hiraoka N
Jpn J Clin Oncol; 2010 Apr; 40(4):313-8. PubMed ID: 20047862
[TBL] [Abstract][Full Text] [Related]
13. Small-cell neuroendocrine carcinoma of the uterine cervix with pancreatic metastasis: a case report and a review of the literature.
Lee EJ; Hwang J; Kim DW
J Obstet Gynaecol; 2019 May; 39(4):573-575. PubMed ID: 30744460
[No Abstract] [Full Text] [Related]
14. Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
Brandi G; Paragona M; Campana D; Brighi N; Bondi A; Pantaleo MA; Corbelli J; Barbera MA; Biasco G
J Chemother; 2018 Feb; 30(1):53-58. PubMed ID: 28641483
[TBL] [Abstract][Full Text] [Related]
15. Giant small-cell neuroendocrine carcinoma infiltrating the heart.
Płatek AE; Kowalik R; Szymanski FM; Filipiak KJ
Kardiol Pol; 2018; 76(6):1023. PubMed ID: 29905370
[No Abstract] [Full Text] [Related]
16. Isolated loss of hormonal receptors in leptomeningeal metastasis from estrogen receptor- and progesterone receptor-positive lobular breast cancer.
Grewal J; Zhou H; Factor R; Kesari S
J Clin Oncol; 2010 May; 28(13):e200-2. PubMed ID: 20124173
[No Abstract] [Full Text] [Related]
17. Estrogen and progesterone receptor expression in the mammary gland tumors.
Moise M; Buruian MM; Ilie C; Zamfir CL; Folescu R; Motoc AG
Rom J Morphol Embryol; 2013; 54(4):961-8. PubMed ID: 24398991
[TBL] [Abstract][Full Text] [Related]
18. Fine needle aspiration biopsy of neuroendocrine breast carcinoma metastatic to the thyroid. A case report.
Loo CK; Burchett IJ
Acta Cytol; 2003; 47(1):83-7. PubMed ID: 12585036
[TBL] [Abstract][Full Text] [Related]
19. Primary neuroendocrine breast carcinoma.
Menéndez P; García E; Rabadán L; Pardo R; Padilla D; Villarejo P
Clin Breast Cancer; 2012 Aug; 12(4):300-3. PubMed ID: 22513033
[No Abstract] [Full Text] [Related]
20. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
